• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性乳腺癌中的汞生物累积与CXCR4表达相关。

Mercury Bioaccumulation in Female Breast Cancer Is Associated to CXCR4 Expression.

作者信息

Servadei Francesca, Bonfiglio Rita, Sisto Renata, Casciardi Stefano, Giacobbi Erica, Scioli Maria Paola, Palumbo Valeria, Buonomo Claudio Oreste, Melino Gerry, Mauriello Alessandro, Scimeca Manuel

机构信息

Department of Experimental Medicine, Tor Vergata Oncoscience Research (TOR), University of Rome "Tor Vergata", 00133 Rome, Italy.

Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, INAIL Research, Monte Porzio Catone, 00078 Rome, Italy.

出版信息

Int J Mol Sci. 2025 May 7;26(9):4427. doi: 10.3390/ijms26094427.

DOI:10.3390/ijms26094427
PMID:40362664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12073024/
Abstract

The growing incidence of breast cancer over time suggests that environmental factors might contribute to the underlying causes of the disease. Mercury, a toxic metal classified as a Substance of Very High Concern, accumulates in the body through contaminated food, air, water, and soil, raising concerns about its role in tumor biology. The main aim of this study was to identify the possible associations between in situ mercury bioaccumulation and the molecular features of breast cancer. To achieve this, a total of 26 breast cancer cases were analyzed using an integrated approach that combined DNA and RNA sequencing, histological analysis, and inductively coupled plasma mass spectrometry (ICP-MS) to assess mercury bioaccumulation. Mercury was detected in 72% of the cases. A significant positive correlation was found between mercury bioaccumulation and CXCR4 expression in breast cancer tissues. Bioinformatic analysis further revealed that CXCR4 expression was significantly higher in metastatic tissues compared to primary tumors. These findings suggest that mercury accumulation may influence tumor biology through the CXCR4-CXCL12 signaling pathway, highlighting a potential mechanism by which mercury contributes to breast cancer progression.

摘要

随着时间的推移,乳腺癌发病率不断上升,这表明环境因素可能是该疾病潜在病因的一部分。汞是一种被列为高度关注物质的有毒金属,可通过受污染的食物、空气、水和土壤在体内蓄积,这引发了人们对其在肿瘤生物学中作用的担忧。本研究的主要目的是确定体内汞生物蓄积与乳腺癌分子特征之间的可能关联。为实现这一目标,采用DNA和RNA测序、组织学分析以及电感耦合等离子体质谱法(ICP-MS)相结合的综合方法,对总共26例乳腺癌病例进行分析,以评估汞的生物蓄积情况。在72%的病例中检测到了汞。在乳腺癌组织中,发现汞生物蓄积与CXCR4表达之间存在显著正相关。生物信息学分析进一步显示,与原发性肿瘤相比,转移组织中的CXCR4表达显著更高。这些发现表明,汞蓄积可能通过CXCR4-CXCL12信号通路影响肿瘤生物学,凸显了汞促进乳腺癌进展的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/12c92c913776/ijms-26-04427-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/59222af9561b/ijms-26-04427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/65de33c4c87f/ijms-26-04427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/4a5c6255487b/ijms-26-04427-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/12c92c913776/ijms-26-04427-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/59222af9561b/ijms-26-04427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/65de33c4c87f/ijms-26-04427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/4a5c6255487b/ijms-26-04427-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/12073024/12c92c913776/ijms-26-04427-g004.jpg

相似文献

1
Mercury Bioaccumulation in Female Breast Cancer Is Associated to CXCR4 Expression.女性乳腺癌中的汞生物累积与CXCR4表达相关。
Int J Mol Sci. 2025 May 7;26(9):4427. doi: 10.3390/ijms26094427.
2
Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.CXCL12、CXCR4和CXCR7在乳腺癌患者中的预后意义。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13217-24. eCollection 2015.
3
Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.趋化因子 CXCL12 被 CXCR7 清除可促进 CXCR4 阳性乳腺癌细胞的肿瘤生长和转移。
Oncogene. 2012 Nov 8;31(45):4750-8. doi: 10.1038/onc.2011.633. Epub 2012 Jan 23.
4
Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.CXCR4 及其配体 CXCL12 的表观遗传改变作为散发性乳腺癌的预后因素。
PLoS One. 2011;6(12):e29461. doi: 10.1371/journal.pone.0029461. Epub 2011 Dec 29.
5
Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.启动子高甲基化导致CXCL12 mRNA表达下调及其与人类乳腺癌转移进展的关系
J Cancer Res Clin Oncol. 2009 Jan;135(1):91-102. doi: 10.1007/s00432-008-0435-x. Epub 2008 Aug 1.
6
Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.侵袭性乳腺癌中CXC趋化因子受体4-CXC趋化因子配体12轴的上调:一种预测淋巴结转移的有效生物标志物。
J Cancer Res Ther. 2018 Jan-Mar;14(2):345-350. doi: 10.4103/0973-1482.177221.
7
Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.乳腺癌转移:FOXP3 调节 CXCR4 表达和对 CXCL12 反应的证据。
J Pathol. 2014 Sep;234(1):74-85. doi: 10.1002/path.4381. Epub 2014 Jul 9.
8
Leptin promotes bone metastasis of breast cancer by activating the SDF-1/CXCR4 axis.瘦素通过激活 SDF-1/CXCR4 轴促进乳腺癌骨转移。
Aging (Albany NY). 2020 Aug 18;12(16):16172-16182. doi: 10.18632/aging.103599.
9
The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.CXCL12-CXCR4 趋化因子通路:调控淋巴管生成的新轴。
Clin Cancer Res. 2012 Oct 1;18(19):5387-98. doi: 10.1158/1078-0432.CCR-12-0708. Epub 2012 Aug 29.
10
Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.乳腺癌转移至肝和肺是由 Pit-1-CXCL12-CXCR4 轴促进的。
Oncogene. 2018 Mar;37(11):1430-1444. doi: 10.1038/s41388-017-0036-8. Epub 2018 Jan 11.

本文引用的文献

1
Exposure to a contaminated environment and its relationship with human health: Mercury effect on loss of functionality and increased oxidative stress of blood cells.接触受污染环境及其与人类健康的关系:汞对血细胞功能丧失和氧化应激增加的影响。
J Hazard Mater. 2025 Jul 15;492:138088. doi: 10.1016/j.jhazmat.2025.138088. Epub 2025 Mar 29.
2
CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer.CXCR4促进雌激素受体阳性乳腺癌中的肿瘤干性维持及对细胞周期蛋白依赖性激酶4/6(CDK4/6)抑制剂的耐药性。
Breast Cancer Res. 2025 Jan 28;27(1):15. doi: 10.1186/s13058-025-01965-3.
3
Platinum drugs upregulate CXCR4 and PD-L1 expression via ROS-dependent pathways, with implications for novel combined treatment in gastric cancer.
铂类药物通过活性氧依赖性途径上调CXCR4和PD-L1表达,对胃癌新的联合治疗具有启示意义。
J Pathol Clin Res. 2025 Jan;11(1):e70015. doi: 10.1002/2056-4538.70015.
4
Aluminum Concentration Is Associated with Tumor Mutational Burden and the Expression of Immune Response Biomarkers in Colorectal Cancers.铝浓度与结直肠癌中的肿瘤突变负担及免疫反应生物标志物的表达相关。
Int J Mol Sci. 2024 Dec 13;25(24):13388. doi: 10.3390/ijms252413388.
5
Tumor specimen cold ischemia time impacts molecular cancer drug target discovery.肿瘤标本冷缺血时间影响分子癌症药物靶点发现。
Cell Death Dis. 2024 Sep 26;15(9):691. doi: 10.1038/s41419-024-07090-x.
6
A comprehensive molecular characterization of a claudin-low luminal B breast tumor.一个 Claudin-低腔型 luminal B 乳腺肿瘤的全面分子特征分析。
Biol Direct. 2024 Aug 16;19(1):66. doi: 10.1186/s13062-024-00482-1.
7
Elemental biomapping of human tissues suggests toxic metals such as mercury play a role in the pathogenesis of cancer.人体组织的元素生物图谱表明,汞等有毒金属在癌症发病机制中起作用。
Front Oncol. 2024 Jun 21;14:1420451. doi: 10.3389/fonc.2024.1420451. eCollection 2024.
8
Molecular profiling of a bladder cancer with very high tumour mutational burden.具有极高肿瘤突变负荷的膀胱癌的分子特征分析。
Cell Death Discov. 2024 Apr 30;10(1):202. doi: 10.1038/s41420-024-01883-x.
9
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
10
Heavy metals in biological samples of cancer patients: a systematic literature review.癌症患者生物样本中的重金属:一项系统文献综述。
Biometals. 2024 Aug;37(4):803-817. doi: 10.1007/s10534-024-00583-4. Epub 2024 Feb 12.